The Quarterly Provider Update provides a listing of Agency regulations and meeting notices. Non-regulatory changes to the Medicare and Medicaid programs, consisting of manual instructions, are also included in this listing.
R9NCD | NCD - Ocular Photodynamic Therapy (OPT) With Verteporfin for Age-Related Macular Degeneration (AMD) | 04/01/2004 | 04/01/2004 |
R9NCD | NCD - Ocular Photodynamic Therapy (OPT) With Verteporfin for Age-Related Macular Degeneration (AMD) | 04/01/2004 | 04/01/2004 |
R9NCD | NCD - Ocular Photodynamic Therapy (OPT) With Verteporfin for Age-Related Macular Degeneration (AMD) | 04/01/2004 | 04/01/2004 |
R9NCD | NCD - Ocular Photodynamic Therapy (OPT) With Verteporfin for Age-Related Macular Degeneration (AMD) | 04/01/2004 | 04/01/2004 |
R9NCD | NCD - Ocular Photodynamic Therapy (OPT) With Verteporfin for Age-Related Macular Degeneration (AMD) | 04/01/2004 | 04/01/2004 |
R9NCD | NCD - Ocular Photodynamic Therapy (OPT) With Verteporfin for Age-Related Macular Degeneration (AMD) | 04/01/2004 | 04/01/2004 |
R9NCD | NCD - Ocular Photodynamic Therapy (OPT) With Verteporfin for Age-Related Macular Degeneration (AMD) | 04/01/2004 | 04/01/2004 |
R9NCD | (PDF - 413 KB) NCD - Ocular Photodynamic Therapy (OPT) With Verteporfin for Age-Related Macular Degeneration (AMD) | 04/01/2004 | 04/01/2004 |
R9NCD | NCD - Ocular Photodynamic Therapy (OPT) With Verteporfin for Age-Related Macular Degeneration (AMD) | 04/01/2004 | 04/01/2004 |
R9NCD | NCD - Ocular Photodynamic Therapy (OPT) With Verteporfin for Age-Related Macular Degeneration (AMD) | 04/01/2004 | 04/01/2004 |